Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa. (Q54042377)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa. |
scientific article |
Statements
Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa. (English)
J E Ahlskog
1 reference
A Lieberman
S Imke
M Muenter
K Wheeler
J Y Matsumoto
D M Maraganore
K F Wright
J Schoenfelder
1 October 1993
43
10
1981-1984